title: [Cancer diagnosis during pregnancy: importance of a national and European registration].
abstract: Cancer during pregnancy is relatively rare, but its incidence has been increasing over recent years. A European study has been launched in 2005 by F. Amant (KUL) to register all pregnant patients with a cancer diagnosis with or without treatment during pregnancy (surgery, chemotherapy and/or radiotherapy). All infants exposed to chemotherapy and/or radiotherapy are also followed up by pediatricians, neurologists, cardiologists and psychologists. In Belgium, French- and Dutch- language hospitals are working in close collaboration to follow these pregnant patients. The national results are summarized in this paper.
authors.affiliation: Dienst Gynaécologie en Verloskunde, KUL, UZ Leuven, Belgique. mmhallem@hotmail.com
authors.forename: M Mhallem
authors.initials: MM
authors.lastname: Gziri
authors.forename: F
authors.initials: F
authors.lastname: Goffin
authors.forename: F
authors.initials: F
authors.lastname: Debieve
authors.forename: F
authors.initials: F
authors.lastname: Amant
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001530:Belgium; D003299:Cooperative Behavior; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008875:Middle Aged; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D012042:Registries; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents